Latest filing published 09 Jul 2009 for Acadia Pharmaceuticals INC, €7,699.
Insider track record
No signal scores available.
Bo-Ragnar Tolf: trading record in brief
Bo-Ragnar Tolf discloses dealings in Acadia Pharmaceuticals Inc to SEC (Form 4). The record holds 2 filings, all for trades on 8 July 2009.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 9 July 2009 with an option exercise (€7,699) in Acadia Pharmaceuticals Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Bo-Ragnar Tolf
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$1.08Common StockSEC:0001181431-09-034837:0
1 of 1 declaration
